Clinical efficacy and safety of polatuzumab vedotin, rituximab, and zanubrutinib (POLA-Z-R) therapy in treatment of super-elderly patients with DLBCL: A real-world retrospective study
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Rong Xie, Qiang He, Linna Xie, Lili Feng, Qi Kong, Kuntong Liu, Ziqing Ma, Yuhong Ba, Zonghong Li, Qian Wu, Tan Sang, Y. Lynn Wang, Ji Ma
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417015027
Cites:
Cited by:
Related to: